ECONOMIC BURDEN OF NEWLY DIAGNOSED PATIENTS WITH PLANTAR FIBROMATOSIS (PF) IN THE UNITED STATES (US)

被引：0
|
作者：
Djatche, L. [1 ]
Near, A. [2 ]
Davis, J. [1 ]
Tse, J. [3 ]
Doshi, R. [4 ]
Ortega, L. [1 ]
Hurley, D. [1 ]
Wang, E. J. [2 ]
Armstrong, D. G. [5 ]
机构：
[1] Endo Pharmaceut Inc, Malvern, PA USA
[2] IQVIA, Durham, NC USA
[3] IQVIA, Cambridge, MA USA
[4] IQVIA, Falls Church, VA USA
[5] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD36
引用
收藏
页码：S244 / S244
页数：1
相关论文
共 50 条
  • [1] Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States
    David M. Kern
    M. Soledad Cepeda
    BMC Neurology, 20
  • [2] Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States
    Kern, David M.
    Cepeda, M. Soledad
    BMC NEUROLOGY, 2020, 20 (01)
  • [3] ECONOMIC BURDEN ASSOCIATED WITH PATIENTS DIAGNOSED WITH PEYRONIE'S DISEASE IN THE UNITED STATES
    Ding, Y.
    Hay, J. W.
    VALUE IN HEALTH, 2014, 17 (03) : A157 - A158
  • [4] Economic Burden of Emergency Room (ER) Visits and Hospitalizations Among Newly Diagnosed Multiple Myeloma (NDMM) Patients in the United States
    Maiese, Eric M.
    Zhu, Xinmei
    Wu, Bingcao
    Chen, Yen-Wen
    Ailawadhi, Sikander
    BLOOD, 2019, 134
  • [5] A RETROSPECTIVE OBSERVATIONAL ANALYSIS OF THE HEALTHCARE ECONOMIC BURDEN OF PATIENTS NEWLY DIAGNOSED WITH HEPATOCELLULAR CARCINOMA AND TREATED WITH LOCOREGIONAL THERAPIES IN THE UNITED STATES
    Seal, B.
    Aly, A.
    Healey, M.
    Lingohr-Smith, M.
    Lin, J.
    VALUE IN HEALTH, 2021, 24 : S35 - S35
  • [6] ECONOMIC BURDEN OF DIAGNOSED CONGENITAL CYTOMEGALOVIRUS IN THE UNITED STATES AND JAPAN
    Buck, P.
    Demmler-Harrison, G.
    Anderson, A.
    Marden, J. R.
    Goldschmidt, D.
    Sarathy, K.
    Basnet, S.
    Kirson, N.
    Desai, U.
    Diaz-Decaro, J.
    VALUE IN HEALTH, 2024, 27 (06) : S128 - S129
  • [7] Economic Burden of Hospitalizations for Patients with Newly Diagnosed Acute Myeloid Leukemia in Remission in the United States: Retrospective Analysis of an Administrative Claims Database
    Chen, Clara
    Papademetriou, Eros
    Kiendrebeogo, Zephirin
    Potluri, Ravi
    BLOOD, 2021, 138
  • [8] The lines of loco-regional therapies received and the healthcare economic burden of patients newly diagnosed with hepatocellular carcinoma in the United States.
    Seal, Brian
    Abdulhalim, Abdulla M.
    Lingohr-Smith, Melissa
    Lin, Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [9] Treatment Patterns, Adverse Events, and Economic Burden in a Privately Insured Population of Newly Diagnosed Patients with Chronic Lymphocytic Leukemia in the United States
    Kabadi, Shaum
    Goyal, Ravi K.
    Nagar, Saurabh P.
    Kaye, James A.
    Davis, Keith L.
    Mato, Anthony R.
    BLOOD, 2018, 132
  • [10] Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy
    Huggar, David
    Knoth, Russell L.
    Copher, Ronda
    Cao, Zhun
    Lipkin, Craig
    McBride, Ali
    LeBlanc, Thomas W.
    FUTURE ONCOLOGY, 2022, 18 (32) : 3609 - 3621
12345